1-100

1. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardia death. Chapter 24. In Heart Disease. A textbook of cardiovascular medicine. 5th Edition.

Edited by E. Braunwald, vol 2. W.B. Saunders Co 1999.

2. Report of the Working Group of the National Heart, Lung, and Blood Institute (volume 2): Patietn oriented research -Fundemental and applied sudden

cardiac death. DHEW, NIH Publication No. 82-2035. Eashington DC., US Government Printing Office 1981: 114-122.

3. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from

157 cases. Am Heart J 1989; 117: 151-159.

4. 小西正光．予防疫学に関する研究．平成6年度厚生科学研究補助金成人病対策総合研究事業「突然死に関する研究」（班長　尾前照男）．国立循環器病センター

1995: 233-245.

5. 豊島英明，田辺直仁，他．1心臓性突然死の疫学．新不整脈学．監修杉本恒明，編集井上　博．南江堂 2003: 508-512.

6. 消防庁．平成5-14年版救急救助の現況．1993-2002.

7. 徳留省悟．松尾義裕．突然死の剖検例からの検討．Ther Res 1996; 17: 141-278.

8. 高松道生．剖検例からみた内因性来院時循環呼吸停止（突然死）例の死因の検討．日救急医会誌 2000; 11: 323-332.

9. 八木繁監修．Case Stiudies. ホルター心電図記録中の急死例．Proc. Of the Meeting for Case Studies of Sudden Death during Holter ECG Recording.

Excerpta Medica, Tokyo, July 21, 1990.

10. ホルター中の突然死例調査研究グループ．ホルター中の突然死について: ホルター中の突然死記録例の集計報告（第1報）．心電図 2008; 28: 1-8.

11. 循環器病の診断と治療に関するガイドライン. 不整脈の非薬物治療ガイドライン（2006年改訂版）．http://www. j-circ.or.jp/guideline/pdf/JCS2006

_kasanuki_h.pdf（2010 年6月閲覧）．

12. Wannamethee G, Shaper AG, Macfarlance PW, et al. Risk factors for sudden cardiac death in middle-aged British men. Circulation 1995; 91: 1749-

1756.

13. Kannel WB, Gagnon DR, Cupples LA. Epidemiology of sudden coronary death: population at risk. Can J Cardiol 1990; 6: 439-444.

14. Kannel WB, Cupples LA, D’Agostino RB, et al. Hypertention, antihypertensive treatment, and sudden cononary death. The Framingham Study.

Hypertention 1988; 11: II45-II50.

15. Weijenberg MP, Feskens EJ, Kromhout D. Blood pressure and isolated systolic hypertension and the risk of coronary heart disease and mortality in

elderly men (the Zutphen Elderly Study). J Hypertens 1996; 14: 1159-1166.

16. Scargg R, Stewart A, Jackson R, et al. Alcohol and exercise in myocardial ifnarction and sudden coronary death in men and women. Am J Epidemmiol

1987; 126: 77-85.

17. National Cholesterol Education Program. Second Report of the Expert Panel on Detectin, Evaluation and Treatmetn of High blood Cholesterol in Adults

(Adult treatment panel II). Circulation 1994; 89: 1333-1445.

18. De Bacquer D, de Backer G, Kornitzer M, et al. Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and

women. J Am Coll Cardiol 1998; 32: 680-685.

19. Kors JA, de Bruyne MC, Hoes AW, et al. T-loop morphology as a marker of cardiac events in the elderly. J Electrocardiol 1998; 31 (Suppl): 54-59.

20. Day CP, McComb JM, Campbell RW. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342-344.

21. Hii JT, Wyse DG, Gillis AM, et al. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs

and amiodarone. Circulation 1992; 86: 1376-1382.

22. Kors JA, van Herpen G, van Bemmel JH. QT dispersion as an attribute of T-loop morphology. Circulation 1999; 99: 1458-1463.

23. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36: 1749-1766.

24. Giedrimiene D, Giri S, Giedrimas A, et al. Effects of ischemia on repolarization in patients with single and multivessel coronary disease. Pacing Clin

Electrophysiol 2003; 26: 390-393.

25. Moreno FL, Villanueva T, Karagounis LA, et al. Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction.

TEAM-2 Study Investigators. Circulation 1994; 90: 94-100.

26. Nikiforos S, Hatzisavvas J, Pavlides G, et al. QT-interval dispersion in acute myocardial infarction is only shortened by thrombolysis in myocardial

infarction grade 2/3 reperfusion. Clin Cardiol 2003; 26: 291-295.

27. Kassotis J, Mongwa M, Reddy CV. Effects of angiotensinconverting enzyme inhibi-tor therapy on QT dispersion post acute myocardial infarction.

Pacing Clin Electrophysiol. 2003; 26: 843-848.

28. Kalapura T, Lavie CJ, Jaffrani W, et al. Effects of cardiac rehabilitation and exercise training on indexes of dispersion of ventricular repolarization in

patients after acute myocardial infarction. Am J Cardiol 2003; 92: 292-294.

29. Atchison JD, Campbell RW, Higham PD. Time dependent variability of QT dispersion after acute myocardial infarction and its relation to ventricular

fibrillation: a prospective study. Heart 2000; 84: 504-508.

30. Koide Y, Yotsukura M, Yoshino H, et al. Usefulness of QT dispersion immediately after exercise as an indicator of coronary stenosis independent of

　gender or exercise-induced ST-segment depression. Am J Cardiol 2000; 86: 1312-1317.

31. Parchure N, Batchvarov V, Malik M, et al. Increased QT dispersion in patients with Prinzmetal's variant angina and cardiac arrest. Cardiovasc Res

　2001; 50: 379-385.

32. Kabakci G, Onalan O, Batur MK, et al. What is the optimal evaluation time of the QT dispersion after acute myocardial infarction for the risk

　stratification? Angiology 2001; 52: 463-468.

33. Davey P. QT interval and mortality from coronary artery disease. Prog Cardiovasc Dis 2000; 42: 359-384.

34. Zabel M, Klingenheben T, Franz MR, et al. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction:

　re-sults of a prospective, longterm follow-up study. Circulation 1998; 97: 2543-2550.

35. Bodi V, Sanchis J, Navarro A, et al. QT dispersion within the first 6 months after an acute myocardial infarction: relationship with systolic function, left

　ventricular volumes, infarct related artery status and clinical outcome. Int J Cardiol 2001; 80: 37-45.

36. Kirchhof P, Eckardt L, Arslan O, et al. Prolonged QRS duration increases QT dispersion but does not relate to arrhythmias in survivors of acute

　myocardial infarction. Pacing Clin Electrophysiol 2001; 24: 789-795.

37. Fiol M, Marrugat J, Bergada J, et al. QT dispersion and ventricular fibrillation in acute myocardial infarction. Lancet 1995; 346: 1424.

38. Brendorp B, Elming H, Jun L, et al. DIAMOND Study Group. Danish Investigations Of Arrhythmia and Mortality On Dofetilide: Effect of dofetilide on QT

　dispersion and the prognostic implications of changes in QT dispersion for patients with congestive heart failure. Eur J Heart Fail 2002; 4: 201-206.

39. Gang Y, Ono T, Hnatkova K, et al. ELITE II investigators: QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II

　substudy. Pacing Clin Electrophysiol 2003; 26: 394-400.

40. Padmanabhan S, Silvet H, Amin J, et al. Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: results

　from a cohort of 2265 patients with an ejection fraction of < or =40%. Am Heart J 2003; 145: 132-138.

41. Sawicki PT, Kiwitt S, Bender R. The value of QT interval dispersion for identification of total mortality risk in noninsulin-dependent diabetes mellitus. J

　Intern Med 1998; 243: 49-56.

42. Rossing P, Breum L, Major-Pedersen A, et al. Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med 200; 18:

　199-205.

43. Christensen PK, Gall MA, Major-Pedersen A, et al. QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-

　dependent diabetes. Scand J Clin Lab Invest 2000; 60: 323-332.

44. Orlowska-Baranowska E, Baranowski R, Zakrzewski D, et al. QT interval dispersion analysis in patients with aortic valve stenosis: a prospective study.

　J Heart Valve Dis 2003; 12: 319-324.

45. Kosar F, Tandogan I, Hisar I, et al. The clinical significance of QTc dispersion measurement for risk of syncope in patients with aortic stenosis. J Interv

　Cardiol 2001; 14: 429-432.

46. Turrini P, Corrado D, Basso C, et al. Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic

　right ventricular cardiomyopathy. Circulation 2001; 103: 3075-3080.

47. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes

　in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997; 96: 2038-2047.

48. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocar-diographic manifestations of the long QT syndrome. Circulation 1998;

　98: 1928-1936.

49. Tanabe Y, Inagaki M, Kurita T, et al. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in

　LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 2001; 37: 911-919.

50. Shimizu W, Tanabe Y, Aiba T, et al. Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic

　stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol. 2002; 39: 1984-1991.

51. Takenaka K, Ai T, Shimizu W, et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT

　syndrome. Circulation 2003; 107: 838-844.

52. Shimizu W, Noda T, Takaki H, et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long QT syndrome. J Am Coll Cardiol

　2003; 41: 633-642.

53. Yamaguchi M, Shimizu M, Ino H, et al. T wave peak-toend interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity.

　Clin Sci (Lond) 2003; 105: 671-676.

54. Shimizu M, Ino H, Okeie K, et al. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated

　with a cardiac troponin I mutation than QT dispersion. Clin Cardiol 2002; 25: 335-339.

55. Wolf NM, Varigos GA, Hunt D, et al. Sinus arrhythmia in acute myocardial infarction. Med J Austral 1978; 2: 52-53.

56. Kleiger RE, Miller P, Bigger JT, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Am J Cardiol 1987; 59: 256-262.

57. Farrell TG, Bashir Y, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory

　electrocardiographic variables and the signal averaged electrocardiogram. J Am Coll Cardiol 1991; 18: 687-697.

58. Hohnloser SH, Klingenheben T, et al. Heart rate variability used as an arrhythmia risk stratifier after myocardial infarction. PACE 1997; 20: 2594-2601.

59. La Rovere MT, Bigger JT Jr, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet

　1998; 351: 478-484.

60. Bigger JT Jr, Fleiss JL, et al. Time course of recovery of heart period variability after myocardial iInfarction. J Am Coll Cardiol 1991; 18: 1643-1649.

61. Bigger JT Jr, Fleiss JL, et al. Frequency domain measures of heart period variability and mortality of myocardial infarction. Circulation 1992; 85: 164-

　171.

62. Bigger JT Jr, Fleiss JL, et al. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol

　1993; 21: 729-736.

63. Bigger JT Jr, Fleiss JL, et al. The ability of several shortterm measures of RR variability to predict mortality after myocardial infarction. Circulation 1993;

　88: 927-993.

64. Karcz M, Chojnowska L, Zareba W, et al. Prognostic significance of heart rate variability in dilated cardiomyopathy. Int J

　Cardiol 2003; 87: 75-81.

65. Hoffmann J, Grimm W, et al. Heart rate variability and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. PACE 1996; 19: 1841

　-1844.

66. Fauchier L, Babuty D, et al. Heart rate variability in idiopathic cardiomyopathy: Characteristic and prognostic value. J Am Coll Cardiol 1997; 30: 1009

　-1014.

67. Ajiki K., Murakawa Y, et al. Autonomic nervous system activity in idiopathic dilated cardiomyopathy and in hypertrophic cardiomyopathy. Am J Cardiol

　1993; 71: 1316- 1320.

68. Gilligan DM, Chan WL, et al. Autonomic function in hypertrophic cardiomyopathy. Br Heart J 1993; 69: 525-529.

69. Counichan PJ, Fei L, et al. Assessment of heart rate variability in hypertrophic cardiomyopathy. Circulation 1993; 88: 1682-1690.

70. Fei L, Salada AK, et al. Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy? J Am Coll Caldiol 1995; 26: 472-480.

71. Schmidt G, Malik M, Barthel P, et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction.

　Lancet 1999; 353: 1390- 396.

72. Ghuran A, Reid F La Rovere MT, Schmidt G, et al. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The autonomic tone and

　reflexes after myocardial infarction substudy). Am J Cardiol 2002; 89: 184-190.

73. Barthel P, Schneider R, Bauer A, et al. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation 2003; 108: 1221-1226.

74. Exner DV, Kavanagh KM, Slawnych MP, et al.; REFINE Investigators. Noninvasive risk assessment early after a myocardial infarction the REFINE　

　study. J Am Coll Cardiol 2007; 50: 2275-2284.

75. Cygankiewicz I, Zareba W, Vazquez R, et al. Relation of heart rate turbulence to severity of heart failure. Am J Cardiol 2006; 98: 1635-1640.

76. Zhong JH, Chen XP, Zeng CF, et al. Effect of benazepril on heart rate turbulence in patients dilated ardiomyopathy. Clin Exp Pharmcol Physiol 2007;

　34: 612-616.

77. Moore RK, Groves DG, Barlow PE, et al. Heart rate turbulence and death due tocardiac decompensation in patients with chronic heart failure. Eur J

　Heart Fail 2006; 8: 585-590.

78. Cygankiewicz I, Zareba W, Vazquez R, et al. Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients.

　Heart Rhythm 2008; 5: 1095-1102.

79. Deedwania PC, Stein PK, Koren A, et al. Decreased heart rate variability is an independent predictor of sudden cardiac death in post-MI heart failure:

　results fo the EPHESUS arrhythmia and heart rate variability analysis (abstr). Eur Heart J 2006; 27: 63.

80. Gronfeld GC, Kuck KH, Ptaszynski P, et al. Refined risk stratification by heart rate turbulence in patients with reduced left ventricular function early

　after myocardial infarction: results of the DINAMIT Holter substudy (abstr). Heart Rhythm 2005; 2: S53.

81. Grimm W, Schmidt G, Maisch B, et al. Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic

　dilated cardiomyopathy. J Cardiovasc Electrophysiol 2003; 14: 819-824.

82. Klingenheben T, Ptaszynski P, Hohnloser SH. Heart rate turbulence and other autonomic risk markers for arrhythmia risk stratification in dilated　

　cardiomyopathy. J Electrocardiol 2008; 41: 306-311.

83. Miwa Y, Ikeda T, Sakaki K, et al. Heart rate turbulence as a predictor of cardiac mortality and arrhythmic events in patients with dilated

　cardiomyopathy: a prospective study. J Cardiovasc Electrophydiol 2009.

84. Kawasaki T, Azuma A, Asada S, et al. Heart rate turbulence and clinical prognosis in hypertrophic cardiomyopathy and myocardial infarction. Circ J

　2003; 67: 601-604.

85. Bigger JT Jr, La Rovere MT, Steinman RC, et al. Comparison of baroreflex sensitivity and heart period variability after myocardial infarction. J Am Coll

　Cardiol 1989; 14: 1511-1518.

86. Hohnloser SH, Klingenheben T, van de Loo A, et al. Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular

　tachycardia or ventricular fibrillation. Circulation 1994; 89: 1068-1073.

87. Kingenheben T, Credner S, Gronefeld G, et al. Cardiac autonomic tone in risk stratification after myocardial infarct:results of a prospective long-term

　study of 411consecutive patients. Z Kardiol 1999; 88: 400-409.

88. Garcia Diaz F, Vazquez Garcia R, Fajardo Lopez-Cuervo J, et al. Prognostic evaluation of post-infarction patients using two-dimensional

　echocardiography, late ventricular potentials and baroreflex sensitivity. Rev Esp Cardiol 1998; 51: 27-34.

89. Honzikova N, Fiser B, Semrad B. Critical value of baroreflex sensitivity determined by spectral analysis in risk stratification after myocardial infarction.

　Pacing Clin Electrophysiol 2000; 23: 1965-1967.

90. Schwartz PJ, Vanoli E, Stramba-Badiale M, et al. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in

　conscious dogs with and without a myocardial infarction. Circulation 1988; 78: 969-979.

91. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-

　myocardial infarction risk stratification. Circulation 1992; 85 (1 Suppl): I77-91.

92. La Rovere MT, Bersano C, Gnemmi M, et al. Exerciseinduced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction.

　Circulation 2002; 106: 945-949.

93. Mortara A, Specchia G, La Rovere MT, et al. Patency of infarct-related artery. Effect of restoration of anterograde flow on vagal reflexes. ATRAMI

　(Automatic Tone and Reflexes After Myocardial Infarction) Investigators. Circulation 1996; 93: 1114-1122.

94. La Rovere MT, Pinna GD, Hohnloser SH, et al. Schwartz PJ; ATRAMI Investigators. Autonomic Tone and Reflexes After Myocardial Infarcton.

　Baroreflex sensitivity and heart rate variability in the identification of patients at risk for lifethreatening arrhythmias: implications for clinical trials.

　Circulation 2001; 103: 2072-2077.

95. Osterziel KJ, Dietz R. Improvement of vagal tone by ACE inhibition: a mechanism of cardioprotection in patients with mild-to-moderate heart failure.

　J Cardiovasc Pharmacol 1996; 27, Suppl 2: S25-30.

96. Huikuri HV, Tapanainen JM, Lindgren K, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol

　2003; 42: 652-658.

97. Billman GE. Cardiac autonomic neural remodeling and susceptibility to sudden cardiac dearth: effect of endurance exercise training. Am J Physiol Circ

　Physiol 2009; 297: H1171-H1193.

98. Hohnloser SH, Ikeda T, Cohen RJ. Evidence regarding clinical use of microvolt T-wave alternans. Heart Rhythm 2009; 6: S36-44.

99. Rosenbaum DS, Jackson LE, Smith JM, et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994; 330: 235-241.

100. Ikeda T, Saito H, Tanno K, et al. T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol 2002; 89: 79-82.

文献